Tissue-Specific Reference DNA for Methylation Assay Normalization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methylation assays face challenges in accurately quantifying methylation status due to sample-to-sample variations and the need for reliable normalization controls, particularly when analyzing nucleic acids from complex samples like stool that may contain both tissue and blood components.
Innovation Solution
The use of reference DNAs, such as ZDHHC1, with methylation patterns similar to tissue-specific markers, allows for normalization and quantification by exposing them to the same preparative steps as the marker DNAs, enabling accurate comparison and detection of methylation states in samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional control DNAs (e.g., β-actin) are used for normalization, then general DNA quantification is possible, but tissue cell specificity is lost and background from blood cells interferes with detection
Solution Approach 1:
The patent applies local quality by selecting control DNAs with specific tissue cell characteristics (epithelial cell origin) that match the target marker genes. This ensures the control DNA reflects the local biological context of tissue-derived DNA in stool samples, while excluding blood cell components that would create background interference. The control DNA is specifically chosen to have methylation patterns characteristic of epithelial cells but not blood cells.
Solution Approach 2:
The patent introduces an intermediary control DNA (epithelial cell-specific control DNA) that mediates between the target marker genes and the complex stool sample matrix. This intermediary serves as a reference that experiences the same sample processing steps as the target markers but provides a stable baseline for normalization, effectively filtering out blood cell background through its tissue-specific origin.
2Reliability
If control DNAs are exposed to different preparative steps than marker DNAs, then processing variability is reduced, but assay complexity increases
Solution Approach 1:
The patent merges the processing of control DNA and marker DNA into a unified workflow. Both control DNA and marker DNA undergo identical preparative steps including bisulfite conversion, PCR amplification, and detection. This merging ensures that both experience the same technical variability, allowing for reliable normalization while maintaining assay simplicity through a unified protocol rather than separate processing pathways.
3Measurement precision
If tissue cell-specific marker DNAs are used, then tissue-derived DNA detection is improved, but general DNA input normalization becomes difficult
Solution Approach 1:
The patent creates a universal control DNA solution that serves multiple functions: it acts as both a tissue cell-specific marker for detecting epithelial-derived DNA and as a normalization control for general DNA input quantification. The epithelial cell-specific control DNA can be used across different assay contexts (stool samples, blood samples) and for different purposes (detection, normalization, quality control), providing versatility while maintaining tissue specificity through its origin from epithelial cells.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides reliable normalization and accurate quantitation of methylation levels, allowing for the detection of tissue cells in blood samples and the identification of diseases like metastatic cancer by comparing the relative amounts of marker genes to ZDHHC1 DNA, enhancing the sensitivity and specificity of methylation assays.
Implementation Method 1
processing typically comprises treatment with bisulfite to convert un-methylated dC bases to dU residues, making them more readily distinguishable from the methyl-C residues that are protected from bisulfite conversion
Data Source
AI summary
Provided herein is technology relating to performing methylation assays. In particular, the technology relates to internal controls for methylation assays.